The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microneedles for Trans & Intradermal Drug Delivery Market Research Report 2025
Synopsis
The global Microneedles for Trans & Intradermal Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia and Valeritas, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery.
Report Scope
The Microneedles for Trans & Intradermal Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microneedles for Trans & Intradermal Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedles for Trans & Intradermal Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Segment by Application
Drugs
Vaccines
Proteins
Peptides
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Microneedles for Trans & Intradermal Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia and Valeritas, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery.
Report Scope
The Microneedles for Trans & Intradermal Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microneedles for Trans & Intradermal Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedles for Trans & Intradermal Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Segment by Application
Drugs
Vaccines
Proteins
Peptides
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Microneedles for Trans & Intradermal Drug Delivery Market Overview
1.1 Product Overview and Scope of Microneedles for Trans & Intradermal Drug Delivery
1.2 Microneedles for Trans & Intradermal Drug Delivery Segment by Type
1.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Value Comparison by Type (2024-2030)
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolvable Microneedles
1.3 Microneedles for Trans & Intradermal Drug Delivery Segment by Application
1.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Value by Application: (2024-2030)
1.3.2 Drugs
1.3.3 Vaccines
1.3.4 Proteins
1.3.5 Peptides
1.3.6 Others
1.4 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue 2019-2030
1.4.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales 2019-2030
1.4.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Microneedles for Trans & Intradermal Drug Delivery Market Competition by Manufacturers
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Manufacturers (2019-2024)
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Manufacturers (2019-2024)
2.4 Global Microneedles for Trans & Intradermal Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Product Type & Application
2.7 Microneedles for Trans & Intradermal Drug Delivery Market Competitive Situation and Trends
2.7.1 Microneedles for Trans & Intradermal Drug Delivery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microneedles for Trans & Intradermal Drug Delivery Players Market Share by Revenue
2.7.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microneedles for Trans & Intradermal Drug Delivery Retrospective Market Scenario by Region
3.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region: 2019-2030
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region: 2019-2024
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region: 2025-2030
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2019-2030
3.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2019-2024
3.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2025-2030
3.4 North America Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.4.1 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2019-2030)
3.4.3 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2019-2030)
3.5.3 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.6.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2019-2030)
3.6.3 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2019-2030)
3.7.3 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2019-2030)
3.8.3 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2019-2030)
4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2019-2024)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2025-2030)
4.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2019-2030)
4.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2019-2030)
4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2019-2024)
4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2025-2030)
4.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2019-2030)
4.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2019-2030)
5 Segment by Application
5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2019-2030)
5.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2019-2024)
5.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2025-2030)
5.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2019-2030)
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2019-2030)
5.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2019-2024)
5.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2025-2030)
5.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2019-2030)
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Becton Dickinson
6.1.1 Becton Dickinson Corporation Information
6.1.2 Becton Dickinson Description and Business Overview
6.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.1.5 Becton Dickinson Recent Developments/Updates
6.2 Nanopass Technologies
6.2.1 Nanopass Technologies Corporation Information
6.2.2 Nanopass Technologies Description and Business Overview
6.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.2.5 Nanopass Technologies Recent Developments/Updates
6.3 Radius Health
6.3.1 Radius Health Corporation Information
6.3.2 Radius Health Description and Business Overview
6.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.3.5 Radius Health Recent Developments/Updates
6.4 Clearside Biomedical
6.4.1 Clearside Biomedical Corporation Information
6.4.2 Clearside Biomedical Description and Business Overview
6.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.4.5 Clearside Biomedical Recent Developments/Updates
6.5 Dr. Prausnitz Group
6.5.1 Dr. Prausnitz Group Corporation Information
6.5.2 Dr. Prausnitz Group Description and Business Overview
6.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.5.5 Dr. Prausnitz Group Recent Developments/Updates
6.6 Zosano Pharma
6.6.1 Zosano Pharma Corporation Information
6.6.2 Zosano Pharma Description and Business Overview
6.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.6.5 Zosano Pharma Recent Developments/Updates
6.7 Corium International
6.6.1 Corium International Corporation Information
6.6.2 Corium International Description and Business Overview
6.6.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.7.5 Corium International Recent Developments/Updates
6.8 Circassia
6.8.1 Circassia Corporation Information
6.8.2 Circassia Description and Business Overview
6.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.8.5 Circassia Recent Developments/Updates
6.9 Valeritas, Inc.
6.9.1 Valeritas, Inc. Corporation Information
6.9.2 Valeritas, Inc. Description and Business Overview
6.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.9.5 Valeritas, Inc. Recent Developments/Updates
6.10 BD Medical
6.10.1 BD Medical Corporation Information
6.10.2 BD Medical Description and Business Overview
6.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.10.5 BD Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedles for Trans & Intradermal Drug Delivery Industry Chain Analysis
7.2 Microneedles for Trans & Intradermal Drug Delivery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedles for Trans & Intradermal Drug Delivery Production Mode & Process
7.4 Microneedles for Trans & Intradermal Drug Delivery Sales and Marketing
7.4.1 Microneedles for Trans & Intradermal Drug Delivery Sales Channels
7.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
7.5 Microneedles for Trans & Intradermal Drug Delivery Customers
8 Microneedles for Trans & Intradermal Drug Delivery Market Dynamics
8.1 Microneedles for Trans & Intradermal Drug Delivery Industry Trends
8.2 Microneedles for Trans & Intradermal Drug Delivery Market Drivers
8.3 Microneedles for Trans & Intradermal Drug Delivery Market Challenges
8.4 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
